Buy Like Buffett
Watchlist

Flagship explainer

How INOGEN, INC. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$295M · 100%Cost of revenue$164M · 55%Gross profit$154M · 52%Operating income−$30.2M · −10%Income before tax−$23.4M · −8%Income tax−$632000 · −0%Net income−$22.7M · −8%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$295M100%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
Cost of revenue$164M55%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
$154M52%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
−$30.2M−10%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
Income before tax−$23.4M−8%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
Income tax−$632000−0%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
−$22.7M−8%
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
Source:
  • 10-K · FY 2025Filing detailsAccession 0001193125-26-082630 · filed Feb 27, 2026
· event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full INOGEN, INC. analysis at Buy Like Buffett